Delivery Order SPE2DB20D9331-SPE2DB25FL1W2
Award Date 8/29/25
Potential Completion Date 9/22/25
Potential Value $32K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $32,499.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 7, 2025, for the supply of Stelara 90 mg/mL syringes. The contract, which carries no set-aside designation, is scheduled for completion by August 28, 2025, with performance conducted at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has been registered in the System for Award...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor on this award. This delivery...
- The Defense Logistics Agency (DLA) awarded a $16,249.95 delivery order to DMS Pharmaceutical Group Inc. on August 28, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price contract is set to conclude by September 19, 2025, with performance occurring at the vendor's location in Park Ridge, Illinois. The delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market despite its status as a woman-owned small business. DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for Stelara 90mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. The delivery order, which carries no set-aside designation, is scheduled for completion by August 11, 2025, with performance at the contractor's Park Ridge, Illinois location. This award represents a single...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on July 29, 2025, for the supply of Stelara 90 mg/mL syringes with a ceiling value of $16,249.95. This firm fixed-price delivery order is expected to reach ultimate completion by August 19, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a...
- The Defense Logistics Agency awarded a delivery order valued at $64,999.80 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, which is scheduled for completion by August 22, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor on this award. The delivery order is...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. Stelara is a biologic immunosuppressant medication used to treat autoimmune conditions and is commonly stocked in military and federal healthcare facilities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The...